Swiss TPH
Swiss TPH
Location: Basel - North West Switzerland
Category: Health
Affiliation: University of Basel
Swiss TPH is a public-law institution and currently receives 22% of its annual income of around 105 million Swiss francs from the cantons of Basel-Stadt and Basel-Landschaft, the federal government and the University of Basel. The remaining 78% is raised competitively from funding agencies, foundations and clients.
Since January 2022, the institute has its headquarters in Allschwil in the Canton of Basel-Landschaft. The Centre for Tropical and Travel Medicine has been located in Basel-Stadt since January 2024.
Associated Institute of the University of Basel
As an associate institute of the University of Basel, Swiss TPH has a teaching role at various faculties, as well as in postgraduate education and training at national and international level.
news.myScience
Four billion people estimated to lack access to safe drinking water
More than half of the global population is estimated to lack safe drinking water services in a study published yesterday in the journal Science. The results are depicted in a map that researchers compiled using machine learning based on data from household surveys and data derived from earth observations. The study was led by the Swiss Federal Institute of Aquatic Science and Technology (Eawag) and supported by Swiss TPH, WHO, UNICEF and ETH Zurich.
New Study Confirms Efficacy of Emodepside Against Parasitic Worm Infections
Researchers at Swiss TPH have demonstrated that the novel drug candidate, emodepside, is highly effective in treating parasitic worm infections in humans, particularly hookworms. The results of a Phase 2b trial, published today in The Lancet, confirmed the drug's strong efficacy and safety profile, building on the promising outcomes of an earlier Phase 2a study. Swiss TPH is collaborating with Bayer to further develop emodepside.
Launch of Swiss TPH Alumni Network
Since the founding of Swiss TPH in 1943, education and training has been a cornerstone of our activities. Our diverse community of graduates works around the globe in research institutions, governments, multilateral organisations, NGOs and the private sector, driving change and improving the health and well-being of people. To further strengthen the connection with our alumni, Swiss TPH today officially launches an alumni network, the Swiss TPH AlumNet.
More than sneezing: Pollen increases blood pressure
An estimated one-fifth of the world's population is affected by pollen allergies. Researchers at Swiss TPH have now discovered that high pollen concentrations can increase blood pressure in allergy sufferers. Pollen allergies are thus becoming a growing public health problem, especially as the pollen season is becoming longer and more intense due to climate change. The research findings were published today in the journal Environmental Research
Swiss TPH Annual Report Is Out Now!
The Annual Report 2023 highlights our achievements in improving the health of people worldwide, with a particular focus on drug development for poverty-related diseases and looks back at our Open House event, celebrating the 80th anniversary of Swiss TPH.
Heat as a Health Risk: Need for Action to Raise Public Awareness
On behalf of the federal government, Swiss TPH conducted the first nationally representative population survey in Switzerland about heat and its effects on health. The results show that the population is generally well-informed about how to protect themselves from heat. Nonetheless, many behavioural measures that help on hot days are either not known about or not actively implemented. This can lead to avoidable health consequences due to heat.
Strengthening Swiss-Ivorian Research Partnership
Swiss TPH and the Centre Suisse de Recherches Scientifiques en Côte d'Ivoire (CSRS) have a long-standing partnership.
Chronic Pain and Pastoralists in Ethiopia
Chronic pain is a significant global health concern and access to pain control is a basic human right.
Ministers of Health from Rwanda and Senegal Visit Swiss TPH
Yesterday, Sabin Nsanzimana, Minister of Health from Rwanda and Ibrahima Sy, Ministre de la Santé et de l'Action Sociale from Senegal, visited Swiss TPH. The delegations discussed health sector priorities in their respective countries as well as current and potential future collaborations with Swiss TPH in the fields of research, education and services. The two ministers - both Swiss TPH alumni - also took the time to interact with students.
Hay Fever on the Increase Due to Climate Change
The hay fever situation in Switzerland is deteriorating because of climate change: the hay fever season is becoming longer, pollen concentrations are increasing, and highly allergenic invasive plants are becoming widespread.
Positive Efficacy and Safety Data for a Novel Treatment for Small Babies
Novartis and Medicines for Malaria Venture (MMV) announce positive data from their phase II/III CALINA study, demonstrating that a novel formulation of Coartem (artemether-lumefantrine) developed for babies weighing less than 5kg with malaria has the required pharmacokinetic profile and good efficacy and safety. The trial was conducted in several African countries. Swiss TPH was in charge of carrying out the study in the Democratic Republic of Congo.
Advert
